Bluefin Capital Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-128,100
Closed -$3.2K 379
2022
Q4
$3.2K Hold
128,100
﹤0.01% 393
2022
Q3
$7K Hold
128,100
﹤0.01% 479
2022
Q2
$9K Hold
128,100
﹤0.01% 494
2022
Q1
$84K Sell
128,100
-137,500
-52% -$3M 0.01% 419
2021
Q4
$63K Buy
+265,600
New +$7.34M ﹤0.01% 664
2021
Q3
Sell
-30,000
Closed -$11K 839
2021
Q2
$11K Sell
30,000
-161,500
-84% -$6.56M ﹤0.01% 592
2021
Q1
$111K Buy
+191,500
New +$8.83M 0.01% 541

Other funds holding MSOS

Bluefin Capital Management's MSOS Position: Q1 2022 in Review

Bluefin Capital Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2022, closing a stake of 18,000 shares — an estimated $393K sold.

Bluefin Capital Management first reported a position in MSOS in Q1 2021 and held it in 2 quarters. The position peaked at $461K in Q4 2021. 181 funds tracked by Wall St. Rank hold MSOS as of Q1 2022.

  • Bluefin Capital Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 18,000 AdvisorShares Pure US Cannabis ETF shares in Q1 2022, an estimated $393K.
  • Bluefin Capital Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and held it in 2 quarters.
  • Bluefin Capital Management's AdvisorShares Pure US Cannabis ETF position peaked at $461K in Q4 2021.
  • 181 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.